AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

RESMED INC Director's Dealing 2014

Feb 26, 2014

30071_dirs_2014-02-26_097bad4f-46f7-48f5-b8f6-3ecd987cfcc5.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-02-24

Reporting Person: FARRELL PETER C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-24	ResMed Common Stock	M	4756	$21.025	Acquired	494632	Direct
2014-02-24	ResMed Common Stock	M	6443	$15.52	Acquired	501075	Direct
2014-02-24	ResMed Common Stock	M	3915	$25.54	Acquired	504990	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-24	ResMed Common Stock Options	$21.025	M	4756	Disposed	2014-11-07	ResMed Common Stock (4756)	Direct
2014-02-24	ResMed Common Stock Options	$15.520	M	6443	Disposed	2015-11-20	ResMed Common Stock (6443)	Direct
2014-02-24	ResMed Common Stock Options	$25.540	M	3915	Disposed	2016-12-17	ResMed Common Stock (3915)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	200000	Indirect